COMBING THROUGH LOST ARTICLES OF FAITH

The Boston Globe | October 29, 2003| | Copyright

History, it's often said, is written by the victors. University of North Carolina professor Bart Ehrman argues in a pair of intriguing new books that the same could be said of the Bible's New Testament. That Ehrman makes his case without pushing into territory considered heretical by many mainstream Christians shows a deft touch with the most volatile of subjects.

Ehrman does not suggest Christians are wrong to believe what they read in the 27 texts that, combined, make up the New Testament. He leaves polemics to others. Instead, the longtime religious studies professor tries to explain in ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Antares Receives First FDA Approval of ATD(TM) Gel Platform.
Business Wire ; ...6 Million Payment EWING, N.J. -- Antares Pharma, Inc. (Amex: AIS) announced...E-Gel[R]) in the United States. Antares' development partner, BioSante Pharmaceuticals...Elestrin is the first FDA approved product in Antares' Advanced Transdermal Delivery (ATD...
Antares Agrees to Financing with Farallon Capital Management, L.L.C. 'R'
Newspaper article from: CCNMatthews Newswire ; ...VIOLATION OF U.S. SECURITIES LAW. Antares Minerals Inc. (TSX VENTURE:ANM...subscribed for 3,500,000 "Units" of Antares by way of private placement for an aggregate consideration to Antares of $2,450,000. Farallon also has...
Antares Pharma Receives Milestone Payment.
Business Wire ; ...in Sales Based Milestones EWING, N.J. -- Antares Pharma, Inc. (AMEX: AIS) announced that...milestone payments could bring the total payments to Antares to more than $13 million. Antares also receives an important portion of the royalties...
Antares Pharma Announces Notice of Allowance for Newest ATD(TM) Gel Patent.
Business Wire ; EWING, N.J. -- Antares Pharma, Inc. (Amex:AIS) announced...hormonal formulations developed by Antares Pharma. The patent is expected to issue...2021. This new patent may also provide Antares Pharma with the necessary protection...
Antares' Product Development Agreement Wins 2007 Innovative Bio-Partnering Award.
Business Wire ; ...Significant CNS Disorder EWING, N.J. -- Antares Pharma, Inc. (Amex:AIS) announced...award for innovation in deal making. Antares and Jazz Pharmaceuticals signed a worldwide...significant CNS disorder and is based on Antares' proprietary ATD[TM] (Advanced Transdermal...
Antares Pharma Presents Before the Financial Analysts and Money Managers Society in New York City; - Reports 2002 Revenues Rose 14% - Cash Burn Rate Reduced Nearly 50% - Pursuing Partnerships with Leading Pharmaceutical Companies - 2003 Goals to Significantly Grow Gross Revenues and be Cash Flow Positive by 2004.
PR Newswire ; Antares Pharma, Inc. , in an after market presentation...Chief Executive Officer and President of Antares Pharma, stated that the Company's goals...agreements in 2003." He also noted that Antares Pharma's financial position has improved...
Antares Pharma, Inc. and Ferring Pharmaceuticals Announce Extension of Their Business Relationship for Use of Needle-Free Devices for Delivery of Human Growth Hormone.
PR Newswire ; Antares Pharma, Inc. and Ferring Pharmaceuticals...2 VISION, Ferring's trade name for Antares Pharma's Medi-Jector VISION(R) device...will access next-generation devices from Antares Pharma to further support the development...
Antares Pharma's Licensee Reaches Important Milestone.
PR Newswire ; Antares Pharma's North American Licensee, BioSante...Phase III Clinical Trial for Estradiol Gel Antares Pharma, Inc. announced today that its...2005. Bio-E-Gel(TM) utilizes Antares Pharma's proprietary Advanced Transdermal...
Antares Pharma Announces Commercial Launch of Its First Gel Based Pharmaceutical Product.
Business Wire ; ...Transdermal Estradiol Gel EWING, N.J. -- Antares Pharma, Inc. (AMEX:AIS) announced...menopausal women which is delivered in Antares' proprietary Advanced Transdermal Delivery...rights for Elestrin in the U.S. while Antares maintains the sole rights in Europe and...
Antares Pharma Signs Development Agreement With Company Specializing in CNS Products.
PR Newswire ; ...Dec. 6 /PRNewswire-FirstCall/ -- Antares Pharma, Inc. today announced having...CNS) disorders. Under the agreement, Antares will apply its advanced transdermal delivery...new, branded pharmaceutical product. Antares will recognize research and development...

Find more facts and information related to the article "COMBING THROUGH LOST ARTICLES OF FAITH"